[CAS No.]477600-75-2
[Product]Xeljanz
[Alias]3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile; 3-{(3S,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile; CP 690550
[Indications]: Chronic infectious arthritis
Our newly development 3.1 class new drug 'Xeljanz tablet' will declare clinical research, interested enterprises please contact us.
Product Description:
The FDA has approved the Xeljanz of our company, it is used for the treatment of moderate or severe chronic infectious arthritis (RA).